Wealth Bridge Capital Management, LLC Acadia Pharmaceuticals Inc Transaction History

Wealth Bridge Capital Management, LLC

  • $342 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 13, 2019
SELL
$23.32 - $28.12 $15,624 - $18,840
-670 Closed
0 $0
Q1 2019

May 15, 2019
SELL
$16.17 - $27.38 $2,312 - $3,915
-143 Reduced 17.59%
670 $17,000
Q4 2018

Feb 14, 2019
BUY
$14.32 - $22.92 $11,642 - $18,633
813 New
813 $13,000

Others Institutions Holding ACAD

# of Institutions
280
Shares Held
156M
Call Options Held
901K
Put Options Held
314K
View Full List

About ACADIA PHARMACEUTICALS INC

ACAD Quotes by TradingView
  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.68B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Wealth Bridge Capital Management, LLC Portfolio

Follow Wealth Bridge Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Bridge Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Bridge Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email